Under construction – not a live service
Sign in
Taking people in TaiwanNo phase

Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device

Key facts

Where
Tainan, TaiwanSee the site

Where in Taiwan

  • National Cheng Kung University HospitalTainan, TaiwanContact: Ching-Hsia Hung, PhDTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
National Cheng-Kung University Hospital
Trial code
NCT06103630
Record updated
21 March 2024
Original description
Oropharyngeal muscle training has emerged as a novel adjunctive treatment approach, involving training of the swallowing muscle group and tongue muscles to prevent tongue collapse, reduce tongue base volume during sleep, and strengthen muscle tension.Read full original descriptionShow less

Efficacy of Oropharyngeal Exercises for Patients With Residual Obstructive Sleep Apnea Using Mandibular Advancement Device

Oropharyngeal muscle training has emerged as a novel adjunctive treatment approach, involving training of the swallowing muscle group and tongue muscles to prevent tongue collapse, reduce tongue base volume during sleep, and strengthen muscle tension.

Therefore, the objective is to assess changes in oropharyngeal muscle strength, ultrasonographic tongue morphology, severity of sleep related breathing interruptions, clinical symptoms, and correlations among these factors. Oropharyngeal muscle training for patients with residual OSA using MAD can significantly 1. increase muscle strength and endurance. 2. reduce the severity of sleep-related breathing interruptions. 3. decrease clinical symptoms. 4. improve tongue morphology.

Inclusion: OSA patients; Aged over 20 years; Wearing MAD (The amount of MAD is at least 50% of the maximum amount that the patient can achieve.).

Exclusion: Severe obstructive or restrictive lung disease; Exercise with high-risk cardiovascular disease; History of central or peripheral neurological disease resulting in an inability to perform exercise prescriptions; Musculoskeletal or psychological disorders that prevent the performance of exercise prescriptions; Chronic illnesses that are ongoing or not yet controlled; Body Mass Index (BMI) ≧ 35; Pregnancy.

ClinicalTrials.gov NCT06103630